Henry Patton Doggrell - Net Worth and Insider Trading
Henry Patton Doggrell Net Worth
The estimated net worth of Henry Patton Doggrell is at least $3,021 dollars as of 2024-04-19. Henry Patton Doggrell is the VP, Chief Legal Officer of Oncternal Therapeutics Inc and owns about 341 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $3,021. Details can be seen in Henry Patton Doggrell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Henry Patton Doggrell has not made any transactions after 2018-06-20 and currently still holds the listed stock(s).
Transaction Summary of Henry Patton Doggrell
Henry Patton Doggrell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry Patton Doggrell owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Henry Patton Doggrell’s form 4 insider trades.
Insider Ownership Summary of Henry Patton Doggrell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-06-20 | VP & Chief Legal Officer |
Henry Patton Doggrell Latest Holdings Summary
Henry Patton Doggrell currently owns a total of 1 stock. Henry Patton Doggrell owns 341 shares of Oncternal Therapeutics Inc (ONCT) as of June 20, 2018, with a value of $3,021.
Latest Holdings of Henry Patton Doggrell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2018-06-20 | 341 | 8.86 | 3,021 |
Holding Weightings of Henry Patton Doggrell
Henry Patton Doggrell Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry Patton Doggrell has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 53 shares on June 20, 2018, which brought Henry Patton Doggrell around $139,743.
Insider Trading History of Henry Patton Doggrell
- 1
Henry Patton Doggrell Trading Performance
GuruFocus tracks the stock performance after each of Henry Patton Doggrell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry Patton Doggrell is 31.8%. GuruFocus also compares Henry Patton Doggrell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry Patton Doggrell within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry Patton Doggrell's insider trading performs compared to the benchmark.
Performance of Henry Patton Doggrell
Average Return
7.39%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.57 | 31.8 | 6.79 | 7.39 | -3.93 | 9.02 |
| Relative Return to S&P 500(%) | 11.56 | 28.77 | 4.93 | 0.26 | -11.04 | -0.56 |
Henry Patton Doggrell Ownership Network
Ownership Network List of Henry Patton Doggrell
Ownership Network Relation of Henry Patton Doggrell
Henry Patton Doggrell Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Henry Patton Doggrell is the VP & Chief Legal Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Henry Patton Doggrell made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 980 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,980 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Henry Patton Doggrell Mailing Address
Above is the net worth, insider trading, and ownership report for Henry Patton Doggrell. You might contact Henry Patton Doggrell via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
